TY  - JOUR 
AU  - D'Agostino, Mattia
AU  - Cairns, David A
AU  - Lahuerta, Juan José
AU  - Wester, Ruth
AU  - Bertsch, Uta
AU  - Waage, Anders
AU  - Zamagni, Elena
AU  - Mateos Manteca, María Victoria
AU  - Dall'Olio, Daniele
AU  - van de Donk, Niels W C J
AU  - Jackson, Graham
AU  - Rocchi, Serena
AU  - Salwender, Hans
AU  - Bladé Creixenti, Joan
AU  - van der Holt, Bronno
AU  - Castellani, Gastone
AU  - Bonello, Francesca
AU  - Capra, Andrea
AU  - Mai, Elias K
AU  - Dürig, Jan
AU  - Gay, Francesca
AU  - Zweegman, Sonja
AU  - Cavo, Michele
AU  - Kaiser, Martin F
AU  - Goldschmidt, Hartmut
AU  - Hernández Rivas, Jesús María
AU  - Larocca, Alessandra
AU  - Cook, Gordon
AU  - San-Miguel, Jesús F
AU  - Boccadoro, Mario
AU  - Sonneveld, Pieter
PY  - 2022
UR  - http://hdl.handle.net/10366/171350
AB  - [EN]Patients with newly diagnosed multiple myeloma (NDMM) show heterogeneous outcomes, and approximately 60% of them are at intermediate-risk according to the Revised International Staging system (R-ISS), the standard-of-care risk stratification...
LA  - eng
PB  - ASCO publications
KW  - Multiple Myeloma
KW  - Chromosome Aberrations
KW  - Humans
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Chromosome Aberrations
KW  - Multiple Myeloma
KW  - Risk Factors
KW  - Humans
KW  - Retrospective Studies
TI  - Second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma: a european myeloma network (EMN) report within the HARMONY project
DO  - 10.1200/JCO.21.02614
T2  - Journal of clinical oncology
VL  - 40
M2  - 3406
ER  -